Literature DB >> 22215657

Effluent free radicals are associated with residual renal function and predict technique failure in peritoneal dialysis patients.

Hiroshi Morinaga1, Hitoshi Sugiyama, Tatsuyuki Inoue, Keiichi Takiue, Yoko Kikumoto, Masashi Kitagawa, Shigeru Akagi, Kazushi Nakao, Yohei Maeshima, Ikuko Miyazaki, Masato Asanuma, Makoto Hiramatsu, Hirofumi Makino.   

Abstract

OBJECTIVE: Residual renal function (RRF) is associated with low oxidative stress in peritoneal dialysis (PD). In the present study, we investigated the relationship between the impact of oxidative stress on RRF and patient outcomes during PD.
METHODS: Levels of free radicals (FRs) in effluent from the overnight dwell in 45 outpatients were determined by electron spin resonance spectrometry. The FR levels, clinical parameters, and the level of 8-hydroxy-2'-deoxyguanosine were evaluated at study start. The effects of effluent FR level on technique and patient survival were analyzed in a prospective cohort followed for 24 months.
RESULTS: Levels of effluent FRs showed significant negative correlations with daily urine volume and residual renal Kt/V, and positive correlations with plasma β(2)-microglobulin and effluent 8-hydroxy-2'-deoxyguanosine. A highly significant difference in technique survival (p < 0.05), but not patient survival, was observed for patients grouped by effluent FR quartile. The effluent FR level was independently associated with technique failure after adjusting for patient age, history of cardiovascular disease, and presence of diabetes mellitus (p < 0.001). The level of effluent FRs was associated with death-censored technique failure in both univariate (p < 0.001) and multivariate (p < 0.01) hazard models. Compared with patients remaining on PD, those withdrawn from the modality had significantly higher levels of effluent FRs (p < 0.005).
CONCLUSIONS: Elevated effluent FRs are associated with RRF and technique failure in stable PD patients. These findings highlight the importance of oxidative stress as an unfavorable prognostic factor in PD and emphasize that steps should be taken to minimize oxidative stress in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215657      PMCID: PMC3524850          DOI: 10.3747/pdi.2011.00032

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  32 in total

1.  Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function.

Authors:  Michael V Rocco; Diane L Frankenfield; Barbara Prowant; Pamela Frederick; Michael J Flanigan
Journal:  Perit Dial Int       Date:  2002 May-Jun       Impact factor: 1.756

2.  Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis.

Authors:  C C Szeto; T Y Wong; K B Lai; C W Lam; K N Lai; P K Li
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

3.  N-acetylcysteine improves residual renal function in peritoneal dialysis patients: a pilot study.

Authors:  Leonid Feldman; Michal Shani; Shai Efrati; Ilia Beberashvili; Iris Yakov-Hai; Elena Abramov; Inna Sinuani; Roza Rosenberg; Joshua Weissgarten
Journal:  Perit Dial Int       Date:  2010-08-12       Impact factor: 1.756

4.  Reduced serum hydroxyl radical scavenging activity in erythropoietin therapy resistant renal anemia.

Authors:  Aki Hirayama; Sohji Nagase; Michihiro Gotoh; Atsushi Ueda; Takashi Ishizu; Keigyou Yoh; Kazumasa Aoyagi; Junji Terao; Akio Koyama
Journal:  Free Radic Res       Date:  2002-11

5.  The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2.

Authors:  Fabian Termorshuizen; Johanna C Korevaar; Friedo W Dekker; Jeannette G van Manen; Elisabeth W Boeschoten; Raymond T Krediet
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

6.  Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.

Authors:  Bert Bammens; Pieter Evenepoel; Kristin Verbeke; Yves Vanrenterghem
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

7.  Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor.

Authors:  Mikio Kakishita; Kazufumi Nakamura; Masato Asanuma; Hiroshi Morita; Hironori Saito; Kengo Kusano; Yoichi Nakamura; Tetsuro Emori; Hiromi Matsubara; Takeshi Sugaya; Norio Ogawa; Tohru Ohe
Journal:  J Cardiovasc Pharmacol       Date:  2003-12       Impact factor: 3.105

8.  Significance of 8-hydroxy-2'-deoxyguanosine levels in patients with chronic renal failure.

Authors:  Shigeru Akagi; Yoshio Nagake; Junko Kasahara; Ai Sarai; Takashi Kihara; Hisanori Morimoto; Ai Yano; Kazushi Nakao; Kiyohito Nanba; Haruo Ichikawa; Hirofumi Makino
Journal:  Nephrology (Carlton)       Date:  2003-08       Impact factor: 2.506

9.  Glycoxidation and inflammation in renal failure patients.

Authors:  Melpomeni Peppa; Jaime Uribarri; Weijing Cai; Min Lu; Helen Vlassara
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

10.  Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.

Authors:  Jos van de Kerkhof; Casper G Schalkwijk; Constantijn J Konings; Emile C Cheriex; Frank M van der Sande; Peter G Scheffer; Piet M ter Wee; Karel M Leunissen; Jeroen P Kooman
Journal:  Nephrol Dial Transplant       Date:  2004-04       Impact factor: 5.992

View more
  12 in total

1.  Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis.

Authors:  Sibel Ada; Sibel Ersan; Aykut Sifil; Mehtat Unlu; Efsun Kolatan; Mehmet Sert; Sulen Sarioglu; Osman Yilmaz; Taner Camsari
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

2.  Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Authors:  Hong Xu; Makoto Watanabe; Abdul Rashid Qureshi; Olof Heimbürger; Peter Bárány; Björn Anderstam; Monica Eriksson; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

3.  A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.

Authors:  Masashi Kitagawa; Hitoshi Sugiyama; Hiroshi Morinaga; Tatsuyuki Inoue; Keiichi Takiue; Ayu Ogawa; Toshio Yamanari; Yoko Kikumoto; Haruhito Adam Uchida; Shinji Kitamura; Yohei Maeshima; Kazufumi Nakamura; Hiroshi Ito; Hirofumi Makino
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

4.  Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial.

Authors:  Klaus Kratochwill; Michael Boehm; Rebecca Herzog; Katharina Gruber; Anton Michael Lichtenauer; Lilian Kuster; Dagmar Csaicsich; Andreas Gleiss; Seth L Alper; Christoph Aufricht; Andreas Vychytil
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

5.  Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease.

Authors:  Toshio Yamanari; Hitoshi Sugiyama; Keiko Tanaka; Hiroshi Morinaga; Masashi Kitagawa; Akifumi Onishi; Ayu Ogawa-Akiyama; Yuzuki Kano; Koki Mise; Yasukazu Ohmoto; Kenichi Shikata; Jun Wada
Journal:  Biomed Res Int       Date:  2018-04-03       Impact factor: 3.411

6.  Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine.

Authors:  Florian M Wiesenhofer; Rebecca Herzog; Michael Boehm; Anja Wagner; Markus Unterwurzacher; David C Kasper; Seth L Alper; Andreas Vychytil; Christoph Aufricht; Klaus Kratochwill
Journal:  Front Physiol       Date:  2019-01-21       Impact factor: 4.566

7.  Urine 5MedC, a Marker of DNA Methylation, in the Progression of Chronic Kidney Disease.

Authors:  Akifumi Onishi; Hitoshi Sugiyama; Masashi Kitagawa; Toshio Yamanari; Keiko Tanaka; Ayu Ogawa-Akiyama; Yuzuki Kano; Koki Mise; Katsuyuki Tanabe; Hiroshi Morinaga; Masaru Kinomura; Haruhito A Uchida; Jun Wada
Journal:  Dis Markers       Date:  2019-07-01       Impact factor: 3.434

8.  Oxidative Stress in Peritoneal Dialysis Patients: Association with the Dialysis Adequacy and Technique Survival.

Authors:  Natalia Stepanova; Lesya Korol; Olena Burdeyna
Journal:  Indian J Nephrol       Date:  2019 Sep-Oct

9.  The Impact of Fluid Overload and Variation on Residual Renal Function in Peritoneal Dialysis Patient.

Authors:  Na Tian; Qunying Guo; Qian Zhou; Peiyi Cao; Lingyao Hong; Menghua Chen; Xiao Yang; Xueqing Yu
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

Review 10.  Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature.

Authors:  Vassilios Liakopoulos; Stefanos Roumeliotis; Xenia Gorny; Theodoros Eleftheriadis; Peter R Mertens
Journal:  Oxid Med Cell Longev       Date:  2017-12-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.